Jing G. Gan
No. 20, South Renmin Road
Chengdu, 610041, China
Chengdu, 610041, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications
Glycosylation disorders in pediatric epilepsy: pathophysiology, imaging and precision therapy.
Journal: Frontiers in neurology
Published: May 12, 2026
Correction: Analysis of treatment outcome variations in infantile epileptic spasms syndrome.
Journal: Frontiers in neurology
Published: April 16, 2026
Clinical Analysis of SYNGAP1 Variant-Related Neurodevelopmental Disorders in Chinese Children.
Journal: Clinical genetics
Published: January 22, 2026
Research progress in SYNGAP1-related neurodevelopmental disorders: from pathogenesis to therapeutic strategies.
Journal: Frontiers in neurology
Published: December 22, 2025
Identification of Immune&Driver Molecular Subtypes Optimizes Immunotherapy Strategies for Gastric Cancer.
Journal: International journal of molecular sciences
Published: December 04, 2025
Development and validation of a 28-day mortality risk prediction model for patients with AIDS suffering from sepsis secondary to pulmonary infections in the ICU.
Journal: BMC infectious diseases
Published: December 01, 2025
Analysis of treatment outcome variations in infantile epileptic spasms syndrome.
Journal: Frontiers in neurology
Published: November 19, 2025
Parental autoimmune diseases and offspring's allergic disease: A systematic review and meta-analysis.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: November 18, 2025
Clinical Characteristics and Treatment Outcomes in Children With Non-Acquired Epilepsy: A Cohort Study Based on Genetic Findings.
Journal: Clinical genetics
Published: October 24, 2025
Optimized NMDAR autoantibody detection via combined NR1-4a LCBA and NR1/NR2 fusion FCBA.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: September 19, 2025
Safety and efficacy of one-dose nocturnal levetiracetam for the treatment of self-limited epilepsy with centrotemporal spikes: a randomized clinical trial.
Journal: Scientific reports
Published: April 19, 2025
Last Updated: 09/26/2026